The infamous Ozempic, for example – beloved of celebrities – is commonly used “off-label” for weight loss ... The oldest repurposed drug. Aspirin was originally marketed by drug company Bayer in 1899 ...
It has been used to prevent heart attacks for years. Find out why experts now are saying it may be doing more harm than good ...
Proponents of the approval of aspirin for primary prevention in moderate ... voted 11 to three against the proposed label change. There were a number of reasons that suggested the evidence was ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofigo ...
Bayer Cropscience Ltd., incorporated in the year 1958, is a Mid Cap company (having a market cap of Rs 25,582.39 Crore) operating in Pesticides/Agro Chemicals sector. Bayer Cropscience Ltd. key ...
They have also received speaking and consulting fees from Bayer, Inc. Bayer, Inc. has licensed the Heart-to-Heart tool. For use in clinical practice, the Framingham equations have been ...
The new Werkself magazine is out! Before it goes out exclusively to Bayer 04 members you can now read the big interview with Jeremie Frimpong here at bayer04.de. The 23-year-old played an important ...
Bayern Munich manager Vincent Kompany has described Paris Saint-Germain as “one of the biggest clubs in Europe” ahead of their UEFA Champions League meeting on Tuesday. PSG are enduring a difficult ...
Aspirin should not be used because it increases uric acid and can worsen a flare. Keep in mind that people with kidney disease should avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs), ...
To sign up for Becker's GI & Endoscopy E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need to whitelist our new ...